Stock Markets February 23, 2026

Covestro CEO Confirms Exit at End of 2028 Contract Term

Dr Markus Steilemann to step down after May 31, 2028; Supervisory Board to begin succession process

By Derek Hwang
Covestro CEO Confirms Exit at End of 2028 Contract Term

Covestro AG announced that Chief Executive Officer Dr Markus Steilemann will not extend his contract beyond May 31, 2028. The company’s Supervisory Board will initiate a formal succession process while Steilemann remains in place to hand over responsibilities. Covestro reported EUR 14.2 billion in sales for fiscal year 2024 and employed about 17,500 people across 46 production sites at the end of 2024.

Key Points

  • Dr Markus Steilemann will not extend his contract beyond May 31, 2028 and informed the Chairman of the Supervisory Board of his decision.
  • The Supervisory Board will commence a succession process to appoint the next CEO; Steilemann will stay in post to ensure a smooth transition.
  • Covestro reported EUR 14.2 billion in sales for fiscal year 2024 and had about 17,500 employees across 46 production sites at the end of 2024, serving mobility, building, and electrical and electronics sectors.

Covestro AG has confirmed that Chief Executive Officer Dr Markus Steilemann will not seek a contract extension when his current term expires on May 31, 2028. The company said Steilemann communicated his decision to the Chairman of the Supervisory Board and will not be available for another term after the contract end date.

The Supervisory Board will now start a formal process to identify and appoint a successor to the chief executive role. Covestro said the board will lead the succession activities and that Steilemann will remain in his post through the end of the contract period to facilitate an orderly handover of duties to the incoming CEO.

Covestro is a manufacturer of polymer materials and related components, supplying customers across several industrial segments. The company lists mobility, building, and electrical and electronics among the end markets it serves.

On a fiscal basis, Covestro generated sales of EUR 14.2 billion in 2024. At the end of that year the company employed roughly 17,500 people and operated 46 production sites worldwide. Those operational and financial figures were included in the company’s announcement about the leadership transition timetable.

The company statement makes clear that the current chief executive will remain in place until the stated contract expiry and will assist in transferring responsibilities to his successor. Details about the succession timeline beyond the start of the Supervisory Board process, including candidate names or strategic implications, were not provided in the announcement.


Summary and context in this release are limited to the information the company disclosed: the non-extension of Dr Steilemann’s contract through May 31, 2028; the initiation of a Supervisory Board-led succession process; and the company’s 2024 sales, employee count, and production-site totals.

Risks

  • Leadership succession is underway but the announcement does not identify a successor, creating short-term uncertainty about future executive direction - this could affect company governance decisions.
  • Operational continuity relies on the incumbent remaining until May 31, 2028; any unforeseen change to that timeline could introduce transitional risk for management responsibilities.
  • The company disclosed limited information about the succession process and timing beyond its initiation, leaving open questions about potential strategic shifts once a successor is appointed.

More from Stock Markets

Psyence Biomedical to Exchange Shares with Psyence Labs in $5M Equity Swap Feb 23, 2026 MoonLake Shares Rise After Positive Phase 2 axSpA Data for Sonelokimab Feb 23, 2026 Gossamer Bio Shares Plunge After Seralutinib Misses Primary Endpoint in Phase 3 PROSERA Trial Feb 23, 2026 Hamborner REIT narrows office exposure, issues 2026 FFO and rent guidance Feb 23, 2026 Atomera Shares Slide After $25 Million Registered Direct Offering Is Announced Feb 23, 2026